CN107029189A - Treat the Chinese medicine of coronary heart disease - Google Patents
Treat the Chinese medicine of coronary heart disease Download PDFInfo
- Publication number
- CN107029189A CN107029189A CN201710451021.9A CN201710451021A CN107029189A CN 107029189 A CN107029189 A CN 107029189A CN 201710451021 A CN201710451021 A CN 201710451021A CN 107029189 A CN107029189 A CN 107029189A
- Authority
- CN
- China
- Prior art keywords
- parts
- coronary heart
- heart disease
- chinese medicine
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/28—Mercury; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/413—Gall bladder; Bile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
- A61K36/835—Aquilaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Insects & Arthropods (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Endocrinology (AREA)
- Physiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A kind of Chinese medicine for treating coronary heart disease, it is characterized in that being made by following medicinal material formulas：60g parts of the red sage root 20, 20 60 parts of pseudo-ginseng, 20 60 parts of stiff silkworm (stir-fry), complete 20 60 parts of worm (watt roasting), 20 60 parts of calamus, 20 60 parts of centipede (watt roasting), 20 60 parts of flos caryophylli, 20 60 parts of the banksia rose, 20 60 parts of agalloch eaglewood, 20 60 parts of frankincense (system), 20 60 parts of west safflower, 20 60 parts of rhizoma cyperi, 20 60 parts of dalbergia wood, 20 60 parts of rhizoma Gastrodiae, 20 60 parts of santal, 20 60 parts of radix curcumae, 20 60 parts of wrinkled giant hyssop, 20 60 parts of cinnabar, 20 60 parts of calculus bovis factitius, 20 60 parts of Moschus, 10 30 parts of borneol.The present invention collects the experience of clinic for many years, for the angina pectoris of coronary heart disease category, vertigo, early stage heart infarction, palpitaition, uncomfortable in chest, dizziness, epilepsy, parkinsonism, facial paralysis, paralysis due to windstroke, swooning is intended to the disease such as dead, depressed, can reach resuscitation with aromatics, resolving sputum and the magical curative effect such as calms the nerves.Its scientific formula rationally, compatibility is original, evident in efficacy, treat both principal and secondary aspect of disease, have no toxic side effect, instant effect the features such as；It is adapted to private clinic evolution to cure the disease and situation of all-level hospitals preparation and pharmaceutical factory production Chinese patent drug.
Description
Technical field
The present invention relates to a kind of Chinese medicine, a kind of Chinese medicine for treating coronary heart disease more particularly to evident in efficacy.
Background technology
The traditional Chinese medical science thinks that coronary heart disease is under the jurisdiction of " obstruction of qi in the chest ", the category of " angina pectoris ", hypofunction of YANG QI in chest, the then uncomfortable in chest, chest of mechanism of qi occlusion
Bitterly；Simultaneously because internal organs in the heart lose the warm of yang-energy, cause yin-cold excess, then body fluid is unable to the defeated cloth of transporting for yang-energy retardance, easily gives birth to phlegm
Turbid, the turbid cold air of phlegm hands over resistance, causes blood vessels obstructed, forms hemostasis；Pectoralgia is more violent during hemostasis formation, very then chest pain radiating to the back.With
The growth at age, patients with coronary heart disease visceral-qi function is gradually moved back；Or not old and deficiency of the kidney, the Yang-function insufficiency of kidneyzang, it is impossible to warm each internal organs, cause sun
Decline the stagnation of the circulation of vital energy, hematogenous blockage, occurs qi deficiency to blood stasis；Or kidney yin is short, it is impossible to nourish the moon of internal organs, may also lead to yin deficiency and blood stasis.By
In chest YANG deficiency, the heresy of cold sensation of the genitalia, which is taken advantage of a weak point in opponent's defence, attacks, cold obstruction causing qi stagnation, numbness resistance chest sun, and the obstructed hair of heart is the obstruction of qi in the chest, is also common coronary disease
The cause of disease of disease.《All pathogeny marquis opinions》Say：" cold air visitor is sent out because empty in the vital organs of the human body, on rush between chest, then be the obstruction of qi in the chest." plain thermophilic fertilizer
Sweet savoury or long-term alcohol, taste are damaged, dysfunction of the spleen in transportation and transformation, the turbid interior life of phlegm, hinder thirsty chest sun, mechanism of qi shows freely, sends out as the obstruction of qi in the chest.Coronary heart disease
Patient mental suppresses, feelings will disequilibrium, or overstretched uneasiness, thinks empty excessive, cause hematogenous blockage；Qi depression to blood stasis, the heart arteries and veins stasis of blood
Resistance hair is the obstruction of qi in the chest, and this is equally the cause of disease of common coronary heart disease.Traditional Chinese medicine thinks that dizziness can be caused by wind, phlegm, void, therefore has
" calm not make dizzy ", " dizziness must be caused by phlegm ", the saying of " dizziness must be due to deficiency ".Calm not make dizzy, the traditional Chinese medical science thinks, liver be geomantic omen it
Dirty, main catharsis, property happiness bar reaches, and melancholy angry, catharsis is not normal, qi depression transforming into fire, permits on liver-yang, liver wind agitation above disturbs clear key, sends out and is
Dizziness；The state of an illness shows as having a dizzy spell, and alliteration or pain, dysphoria, insomnia and dreamful sleep, bitter taste tinnitus, red complexion are red, and blood pressure is inclined
Height, this disease is more to be induced because of emotional stimulation, but the reason for also have coronary heart disease.
Angina pectoris that existing Chinese medicine is showed coronary heart disease, vertigo, epileptics, paralysis due to windstroke, facial paralysis, Xin Fubao
Bitterly, the treatment of depression, mainly activating blood and removing stasis Method, a surname's numbness activate yang method, aromatic herbs activating yang method, adjustment taste method, Qi-Yin supplementing therapy；
But above method tends not to organic unity, just for a certain type；Clinically general doctor is difficult to distinguish, so that medicine
Curative effect is not very notable, and the course for the treatment of is long, is difficult recovery from illness；And the Chinese medicine that effect preferably treats coronary heart disease category is researched and developed, one
It is directly the scientific research task of traditional Chinese physician and the pharmacist of traditional Chinese medicine.
The content of the invention
In view of the above problems with theoretical foundation of motherland's traditional Chinese medicine to the pathogensis of coronary heart disease, with reference to existing Chinese medicine to hat
The multiple therapy methods of worry；On the basis of three generations's prescription handed down from one's ancestors, in conjunction with the clinical experience of inventor's more than two decades；There is provided
A kind of Chinese medicine for the treatment of coronary heart disease evident in efficacy.
The Chinese medicine of the treatment coronary heart disease of the present invention, it is characterised in that be made by following raw material medicinal material formulas：
20-60g parts of the red sage root, 20-60 parts of pseudo-ginseng, 20-60 parts of stiff silkworm (stir-fry), full worm (watt roasting) 20-60 parts, calamus 20-60
Part, 20-60 parts of centipede (watt roasting), 20-60 parts of flos caryophylli, 20-60 parts of the banksia rose, 20-60 parts of agalloch eaglewood, 20-60 parts of frankincense (system), west
20-60 parts of safflower, 20-60 parts of rhizoma cyperi, 20-60 parts of dalbergia wood, 20-60 parts of rhizoma Gastrodiae, 20-60 parts of santal, 20-60 parts of radix curcumae, wrinkled giant hyssop
20-60 parts, 20-60 parts of cinnabar, 20-60 parts of calculus bovis factitius, 20-60 parts of Moschus, 10-30 parts of borneol.
The present invention treats the Chinese medicine of coronary heart disease, and the preferred weight part of raw medicinal material formula is：
40 parts of the red sage root, 40 parts of pseudo-ginseng, 40 parts of stiff silkworm (stir-fry), 40 parts of full worm (watt roasting), 40 parts of calamus, centipede (watt roasting) 40
Part, 40 parts of flos caryophylli, 40 parts of the banksia rose, 40 parts of agalloch eaglewood, 40 parts of frankincense (system), 40 parts of west safflower, 40 parts of rhizoma cyperi, dalbergia wood 40 part, day
40 parts of fiber crops, 40 parts of santal, 40 parts of radix curcumae, 40 parts of wrinkled giant hyssop, 40 parts of cinnabar, 40 parts of calculus bovis factitius, 40 parts of Moschus, 20 parts of borneol.
The Chinese medicine of present invention treatment coronary heart disease, its formulation is big honeyed bolus.
The Chinese medicine of present invention treatment coronary heart disease, its formulation can be described any peroral dosage form in pharmacy.
Effect of primary raw material medicinal material is as follows in the present invention：
The red sage root：Improve myocardial ischemia, coronary artery dilator increases myocardial blood flow.
Pseudo-ginseng：Dissipate stasis of blood hemostasis, detumescence ding-tong is promoting blood circulation and removing blood stasis, reducing blood lipid.
Stiff silkworm：Dispelling wind and relieving convulsion, reducing phlegm and resolving masses, relieving convulsion and spasm, wind-expelling pain-stopping.
Full worm：Ceases wind antispastic, dispersing pathogen accumulation is removed obstruction in channels to relieve pain.
Calamus：Have effects that to have one's ideas straightened out, eliminating the phlegm, dissipate wind, the epidemic disease that can dispel intelligence development, physical fitness.
Centipede：Relieving convulsion and spasm, clearing and activating the channels and collaterals, detoxicating and resolving a mass.
Agalloch eaglewood, the banksia rose, cloves, santal：It is that pungent fragrant temperature is logical, the product of analgesic in tune；But agalloch eaglewood specially receives vital qi, kidney yang is controlled partially
The disease of the cold of insufficiency type；The banksia rose specially adjusts stagnant gas, and the disease of the taste stagnation of the circulation of vital energy is controlled partially；Cloves specially treats cold air, and the cold disease of taste actual situation is controlled partially；Santal is special
Reason part of the body cavity above the diaphragm housing the heart and lungs gas is risen, the disease that chest diaphragm coagulates the stagnation of the circulation of vital energy is controlled partially.
Frankincense：The effect of blood-activating and qi-promoting, analgesic, detumescence and promoting granulation.
West safflower：Anticoagulant action effect is obvious.
Rhizoma cyperi：Promoting qi circulation and removing obstruction in the collateral, for stagnation of QI due to depression of the liver, chest gastral cavity ruffian.
Dalbergia wood：Promoting blood circulation to remove blood stasis, analgesic therapy of stopping blooding, sending down abnormally ascending wards off dirty, main pain in chest and hypochondrium.
Rhizoma Gastrodiae：Suppressing hyperactive liver for calming endogenous wind stops convulsion, for dizziness of having a headache, extremity numbness, child convulsion, epilepsy clonus.
Radix curcumae：Regulating qi to disperse stagnation, heart fire-clearing upset-relieving；For chest and abdomen swelling and pain, shouting pain, pyreticosis coma, epilepsy is gone mad.
Wrinkled giant hyssop：Fast gas and in, ward off dirty, clearing damp.
Cinnabar：Tranquilizing mind, clearing heat and detoxicating, improving eyesight；Main demented, palpitation with fear, vexed, insomnia, dizziness, blurred vision.
Calculus bovis factitius：Clear away heart-fire, have one's ideas straightened out, ceases wind, removing toxic substances；For pyreticosis coma, middle wind phlegm fan, twitch, epilepsy is gone mad.
Moschus：Have one's ideas straightened out, ward off dirty, dredging collateral, dissipate the stasis of blood；Control apoplexy, coma due to blocking of the respiratory system, frightened epilepsy, middle evil unhappiness, trusted subordinate sudden and violent pain.
Borneol：Inducing resuscitation of having one's ideas straightened out, clearing away heat to and alleviating pain；Fainted for pyreticosis coma, convulsion, apoplexy coma due to blocking of the respiratory system, bstruction of the circulation of vital energy is fainted cruelly, middle evil is gone into a coma.
The Chinese medicine of present invention treatment coronary heart disease, its advantage and beneficial effect are：Can enriching yin and nourishing kidney, nourishing qi and blood, promoting blood circulation
Stagnation resolvation, regulating qi-flowing for relieving pain；For the angina pectoris in coronary heart disease category, vertigo, early stage heart infarction, palpitaition, uncomfortable in chest, dizziness, epilepsy, handkerchief
The gloomy disease of gold, facial paralysis, paralysis due to windstroke, swooning is intended to the disease such as dead, depressed.This Chinese medicine combines clinical experience for many years, passes through medicine
Active ingredient, which absorbs, reaches that resuscitation with aromatics, resolving sputum such as are calmed the nerves at the magical curative effect.Rationally, compatibility is original for scientific formula of the present invention, treats
Effect is notable, treat both principal and secondary aspect of disease, have no toxic side effect, instant effect the features such as；Production method of the present invention is simple, be adapted to private clinic evolution
Cure the disease, be also suitable for situation of all-level hospitals preparation and pharmaceutical factory production Chinese patent drug.
Clinical therapeutic efficacy of the invention further explained below：
Patient 100 of the invention through more than 20 years clinical observation coronary heart disease category, medication is counted for 5 months, clinical cure 63
Example, accounts for 63%；Notable 32 of effect accounts for 32%, total effective rate 95%, and non-relapse after healing, Small side effects.
Its model case is as follows：
1st, patient female 63 years old；Pectoralgia half a year is more during because of activity, medical in October, 2012.Pectoralgia when readme is quickly walked,
In sample pain is burnt, radiated to back, symptom can be alleviated after resting 2~3 minutes；Hereafter above-mentioned symptom often goes out when quick walking
Existing, position, property, alleviation mode are with foregoing.Hospital diagnosis is coronary heart disease, and the Chinese medicine of present invention treatment coronary heart disease is taken to here
It is two weeks, pained during walking to alleviate, continuous use 4 months, clinical recovery.
2nd, patient man 58 years old；Pectoralgia is gone to a doctor more than 1 year in August, 2009 during because of activity.Occur pectoralgia, table after readme campaign
It is now vexed pain after breastbone, 3~5 minutes symptoms of rest can be alleviated；Hereafter above-mentioned symptom often breaks out when fatigue, activity, and activity is resistance to
Amount gradually lowers；Occur delaying for 1~2 minute after vexed pain after breastbone, sublingual administration nitroglycerin 0.5mg when tranquillization before medical 3 days
Solution, hospital diagnosis coronary heart disease.The Chinese medicine two weeks of present invention treatment coronary heart disease is taken to here, it is pained after activity to alleviate, continuously
Medication 3 months, recovery from illness.
3rd, patient man 55 years old；Pectoralgia more than 1 year when readme is because of activity, after there is pectoralgia, show as vexed pain after breastbone, rest 3
Remission in~5 minutes；Hereafter above-mentioned symptom often breaks out when fatigue, activity, and activity tolerance gradually lowers, and is radiated to back
Bitterly；And often have a dizzy spell, swoon that it is dead to be intended to, hospital diagnosis is coronary heart disease, vertigo.Present invention treatment coronary heart disease is taken to here
Chinese medicine after one month, pained after activity to alleviate, continuous medication 6 months, coronary heart disease, vertigo recovery from illness.
4th, patient man 41 years old；Readme palpitaition, shortness of breath, pectoralgia, more than the moon uncomfortable in chest, electrocardiographic diagnosis is coronary heart disease；Come here just
Examine, take Chinese medicine symptom mitigation after one week of present invention treatment coronary heart disease, symptom disappears after one month；Continue to take 2 months, half a year
Follow-up afterwards, electrocardiogram display recovery from illness.
5th, patient female 50 years old；Feel pectoralgia during because of work, in burning sample pain, and radiated to back, disease after taking a momentary rest
Shape can be alleviated；Hereafter above-mentioned symptom often occurs when work, position, property, alleviates mode with foregoing, and hospital diagnosis is coronary disease
Disease.It is pained after activity to alleviate after Chinese medicine January that present invention treatment coronary heart disease is taken to here, continuous medication 2 months, work is such as
Often, follow-up after half a year, recovery from illness.
Embodiment
In order that those skilled in the art are better understood from the present invention, further is made to the present invention with reference to embodiment
Explanation.
Embodiment 1
Take following weight raw medicinal material：
Red sage root 20g, pseudo-ginseng 60g, stiff silkworm (stir-fry) 20g, full worm (watt roasting) 60g, calamus 20g, centipede (watt roasting) 20g, public fourth
Fragrant 60g, banksia rose 20g, agalloch eaglewood 20g, frankincense (system) 60g, west safflower 20g, rhizoma cyperi 20g, dalbergia wood 20g, rhizoma Gastrodiae 20g, santal 60g,
Radix curcumae 60g, wrinkled giant hyssop 20g, cinnabar 20g, calculus bovis factitius 60g, Moschus 20g, borneol 10g.
Above-mentioned component is pressed《Pharmacy》In the big honey pill agent technique of oral traditional Chinese medicine prepare, the present invention that every ball weight 3g is made is controlled
Treat the medicine pill of coronary heart disease.
Usage and dosage：The medicine pill of present invention treatment coronary heart disease, an oral ball, two times a day.
Points for attention：Quit smoking during medication wine, other are without special taboo.
The Chinese medicine of present invention treatment coronary heart disease, above-mentioned component is pressed《Pharmacy》Middle known production method, can be produced any
It is a kind of《Pharmacy》In described peroral dosage form.
Embodiment 2
Take following weight raw medicinal material：
Red sage root 60g, pseudo-ginseng 20g, stiff silkworm (stir-fry) 60g, full worm (watt roasting) 20g, calamus 60g, centipede (watt roasting) 60g, public fourth
Fragrant 20g, banksia rose 60g, agalloch eaglewood 60g, frankincense (system) 20g, west safflower 60g, rhizoma cyperi 60g, dalbergia wood 60g, rhizoma Gastrodiae 60g, santal 20g,
Radix curcumae 20g, wrinkled giant hyssop 60g, cinnabar 60g, calculus bovis factitius 20g, Moschus 60g, borneol 30g.
Above-mentioned component is pressed《Pharmacy》In the big honey pill agent technique of oral traditional Chinese medicine prepare, the present invention that every ball weight 3g is made is controlled
Treat the medicine pill of coronary heart disease.
Usage and dosage：The medicine pill of present invention treatment coronary heart disease, an oral ball, two times a day.
Points for attention：Quit smoking during medication wine, other are without special taboo.
The Chinese medicine of present invention treatment coronary heart disease, above-mentioned component is pressed《Pharmacy》Middle known production method, can be produced any
It is a kind of《Pharmacy》In described peroral dosage form.
Embodiment 3
Take following weight raw medicinal material：
Red sage root 40g, pseudo-ginseng 40g, stiff silkworm (stir-fry) 40g, full worm (watt roasting) 40g, calamus 40g, centipede (watt roasting) 40g, public fourth
Fragrant 40g, banksia rose 40g, agalloch eaglewood 40g, frankincense (system) 40g, west safflower 40g, rhizoma cyperi 40g, dalbergia wood 40g, rhizoma Gastrodiae 40g, santal 40g,
Radix curcumae 40g, wrinkled giant hyssop 40g, cinnabar 40g, calculus bovis factitius 40g, Moschus 40g, borneol 20g.
Above-mentioned component is pressed《Pharmacy》In the big honey pill agent technique of oral traditional Chinese medicine prepare, the present invention that every ball weight 3g is made is controlled
Treat the medicine pill of coronary heart disease.
Usage and dosage：The medicine pill of present invention treatment coronary heart disease, an oral ball, two times a day.
Points for attention：Quit smoking during medication wine, other are without special taboo.
The Chinese medicine of present invention treatment coronary heart disease, above-mentioned component is pressed《Pharmacy》Middle known production method, can be produced any
It is a kind of《Pharmacy》In described peroral dosage form.
Claims (4)
1. a kind of Chinese medicine for treating coronary heart disease, it is characterised in that be made by following raw material medicinal material formulas：
20-60g parts of the red sage root, 20-60 parts of pseudo-ginseng, 20-60 parts of stiff silkworm (stir-fry), 20-60 parts of full worm (watt roasting), 20-60 parts of calamus, Wu
20-60 parts of centipede (watt roasting), 20-60 parts of flos caryophylli, 20-60 parts of the banksia rose, 20-60 parts of agalloch eaglewood, 20-60 parts of frankincense (system), west safflower
20-60 parts, 20-60 parts of rhizoma cyperi, 20-60 parts of dalbergia wood, 20-60 parts of rhizoma Gastrodiae, 20-60 parts of santal, 20-60 parts of radix curcumae, wrinkled giant hyssop 20-60
Part, 20-60 parts of cinnabar, 20-60 parts of calculus bovis factitius, 20-60 parts of Moschus, 10-30 parts of borneol.
2. the Chinese medicine for the treatment of coronary heart disease according to claim 1, it is characterised in that the parts by weight of raw medicinal material formula are：
40 parts of the red sage root, 40 parts of pseudo-ginseng, 40 parts of stiff silkworm (stir-fry), 40 parts of full worm (watt roasting), 40 parts of calamus, 40 parts of centipede (watt roasting), public affairs
40 parts of cloves, 40 parts of the banksia rose, 40 parts of agalloch eaglewood, 40 parts of frankincense (system), 40 parts of west safflower, 40 parts of rhizoma cyperi, 40 parts of dalbergia wood, rhizoma Gastrodiae 40
Part, 40 parts of santal, 40 parts of radix curcumae, 40 parts of wrinkled giant hyssop, 40 parts of cinnabar, 40 parts of calculus bovis factitius, 40 parts of Moschus, 20 parts of borneol.
3. the Chinese medicine for the treatment of coronary heart disease according to claim 1 or 2, it is characterised in that：Its described formulation is big honeyed bolus.
4. the Chinese medicine for the treatment of coronary heart disease according to claim 1 or 2, it is characterised in that：During its described formulation is pharmacy
Described any peroral dosage form.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710451021.9A CN107029189A (en) | 2017-06-09 | 2017-06-09 | Treat the Chinese medicine of coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710451021.9A CN107029189A (en) | 2017-06-09 | 2017-06-09 | Treat the Chinese medicine of coronary heart disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107029189A true CN107029189A (en) | 2017-08-11 |
Family
ID=59542169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710451021.9A Pending CN107029189A (en) | 2017-06-09 | 2017-06-09 | Treat the Chinese medicine of coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107029189A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111544419A (en) * | 2020-06-11 | 2020-08-18 | 王文龙 | External plaster for coronary heart disease and its film |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104906274A (en) * | 2015-06-09 | 2015-09-16 | 毛显青 | Traditional Chinese medicine for treating coronary heart disease |
-
2017
- 2017-06-09 CN CN201710451021.9A patent/CN107029189A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104906274A (en) * | 2015-06-09 | 2015-09-16 | 毛显青 | Traditional Chinese medicine for treating coronary heart disease |
Non-Patent Citations (1)
| Title |
|---|
| 上海中医药大学附属龙华医院等: "庆余救心丸治疗冠心病心绞痛的疗效观察", 《上海中医药杂志》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111544419A (en) * | 2020-06-11 | 2020-08-18 | 王文龙 | External plaster for coronary heart disease and its film |
| CN111544419B (en) * | 2020-06-11 | 2023-06-23 | 王文龙 | External plaster for coronary heart disease and plaster film thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1927286A (en) | Chinese medicine composition for treating skin disease | |
| CN104248717B (en) | A kind of foot-bath traditional Chinese medicine composition for treating hypertension and preparation method thereof | |
| CN107029189A (en) | Treat the Chinese medicine of coronary heart disease | |
| CN102302550B (en) | Medicament for treating coronary heart disease | |
| CN104906274A (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN102600343B (en) | Traditional Chinese medicinal preparation for treating oral diseases and/or toothache | |
| CN103859865A (en) | Health-care mattress for treating insomnia | |
| CN104547825B (en) | A kind of preparation method for the Chinese medicine composition and its preparation for treating myoneural pain | |
| CN1709458A (en) | Medicine for treating coronary clisease | |
| CN103599438B (en) | A kind of Traditional Chinese medicine tincture for the treatment of osteopathia and preparation method thereof | |
| CN105213519A (en) | A kind of medicine and preparation method thereof for the treatment of prolapse of lumbar intervertebral disc, hyperosteogeny | |
| CN105012908A (en) | Traditional Chinese medicine preparation for treating strain of lumbar muscles | |
| CN111388623B (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN117414351B (en) | Traditional Chinese medicine patch for treating spleen-kidney yang deficiency constipation and preparation method and application thereof | |
| CN100406035C (en) | Chinese medicine preparation for treating protrasion of lumbar intervertebral disc | |
| CN105688038A (en) | Tetanus mixture and preparation method thereof | |
| CN103432290B (en) | A kind of external used medicine for the treatment of lumbar sprain and QI divergeny and preparation method thereof | |
| CN103948804B (en) | A kind of Chinese medicine composition treating lung qi deficiency dermatitis aestivale | |
| CN104623549A (en) | Traditional Chinese medicine preparation for treating costal chondritis | |
| CN116077574A (en) | Medicine for treating rheumatism bone diseases and preparation method thereof | |
| CN104225420A (en) | Traditional Chinese medicine preparation for treating yin-cold stagnation type coronary heart disease and nursing method | |
| CN104208552A (en) | Chinese herba preparation for treating tetanus | |
| CN104096112A (en) | Traditional Chinese medicine composition for treating angina pectoris | |
| CN118021918A (en) | Essential oil composition for preventing and treating blood stasis syndrome and application thereof | |
| CN114344363A (en) | Traditional Chinese medicine composition for preventing and treating tumors and related treatment posthand and foot numbness and pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170811 |
|
| RJ01 | Rejection of invention patent application after publication |